Zobrazeno 1 - 10
of 22
pro vyhledávání: '"James M Lindberg"'
Autor:
Timothy E Newhook, Edik M Blais, James M Lindberg, Sara J Adair, Wenjun Xin, Jae K Lee, Jason A Papin, J Thomas Parsons, Todd W Bauer
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e105631 (2014)
Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinical staging system. Thus, more accurate prognostic tests are needed for PDAC patients to aid treatment decisions.Affymetrix gene expression profiling w
Externí odkaz:
https://doaj.org/article/bd1e56f5edfe469eb69c4306e672b877
Autor:
James M. Lindberg, Timothy E. Newhook, Sara J. Adair, Dustin M. Walters, Alison J. Kim, Edward B. Stelow, J. Thomas Parsons, Todd W. Bauer
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 7, Pp 562-571 (2014)
Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and epidermal growth factor receptor (EGFR) family signaling are drivers of tumorigenesis in pancreatic ductal adenocarcinoma (PDAC). Previous studies have demonstrated that combinatorial tr
Externí odkaz:
https://doaj.org/article/30740983972940199a2365ff81e3d51a
Patient and Caregiver Considerations and Priorities When Selecting Hospitals for Complex Cancer Care
Autor:
Zhi Ven Fong, Motaz Qadan, Carlos Fernandez-del Castillo, Andrew L. Warshaw, James M. Lindberg, William V. Kastrinakis, Ryan D. Nipp, Giles F. Whalen, Keith D. Lillemoe, Lara Traeger, Cristina R. Ferrone, Pei-Wen Lim, Ryan J. Hendrix, David C. Chang
Publikováno v:
Ann Surg Oncol
BACKGROUND: Healthcare policies have focused on centralizing care to high-volume centers in an effort to optimize patient outcomes. However, little is known about patients’ and caregivers’ considerations and selection process when selecting hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278e9b295f359dcc66abe4ac050038b4
https://doi.org/10.1245/s10434-020-09506-2
https://doi.org/10.1245/s10434-020-09506-2
Autor:
Victor M. Zaydfudim, Todd W. Bauer, Damien J. LaPar, Timothy E. Newhook, Reid B. Adams, James M. Lindberg
Publikováno v:
The American Journal of Surgery. 211:102-108
This study compared the morbidity and mortality following hepatectomy for benign liver tumors and hepatic metastases.This retrospective cohort study compared patients who underwent hepatectomy for benign liver tumors and metastases reported to Nation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a2c5f3d3f84bdb47c391ff4314048c
https://doi.org/10.1016/j.amjsurg.2015.06.010
https://doi.org/10.1016/j.amjsurg.2015.06.010
Autor:
Edward B. Stelow, Todd W. Bauer, Sara J. Adair, Dustin M. Walters, Timothy E. Newhook, J. Thomas Parsons, Alison J. Kim, James M. Lindberg
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 7, Pp 562-571 (2014)
Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and epidermal growth factor receptor (EGFR) family signaling are drivers of tumorigenesis in pancreatic ductal adenocarcinoma (PDAC). Previous studies have demonstrated that combinatorial tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d83c88c22e8935b73a2aa84066bb03
http://www.sciencedirect.com/science/article/pii/S1476558614000785
http://www.sciencedirect.com/science/article/pii/S1476558614000785
Autor:
Darrell R. Borger, Timothy M. Pawlik, James M. Lindberg, Vikram Deshpande, Jean-François Gigot, Cristina R. Ferrone, Thomas Yau, Irinel Popescu, Aslam Ejaz, David Cosgrove, Todd W. Bauer, Robert A. Anders, Andrew X. Zhu, Christine Sempoux, T. Clark Gamblin, Ryan T. Groeschl, Ronnie T.P. Poon, Yuhree Kim, Sorin Alexandrescu
Publikováno v:
Annals of Surgical Oncology. 21:3827-3834
The molecular alterations that drive tumorigenesis in intrahepatic cholangiocarcinoma (ICC) remain poorly defined. We sought to determine the incidence and prognostic significance of mutations associated with ICC among patients undergoing surgical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d9bb05a9d72f17f0f68ae744e8fe4f
https://doi.org/10.1245/s10434-014-3828-x
https://doi.org/10.1245/s10434-014-3828-x
Autor:
Timothy E. Newhook, Tona M. Gilmer, Bryce T. Lowrey, Todd W. Bauer, Cheryl A. Borgman, Catharine R. Cowan, Maria E. Chopivsky, Sara J. Adair, Edward B. Stelow, Jayme B. Stokes, Dustin M. Walters, James M. Lindberg, John T. Parsons
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 2, Pp 143-155 (2013)
Mutations of the oncogene KRAS are important drivers of pancreatic cancer progression. Activation of epidermal growth factor receptor (EGFR) and human EGFR2 (HER2) is observed frequent in pancreatic adenocarcinomas. Because of co-activation of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc5ab09b4a066d38d3af5d55b3cbc21
http://www.sciencedirect.com/science/article/pii/S1476558613800255
http://www.sciencedirect.com/science/article/pii/S1476558613800255
Autor:
J. Thomas Parsons, Osama E. Rahma, Alison J. Kim, James M. Lindberg, Timothy E. Newhook, Sara J. Adair, Edward B. Stelow, Todd W. Bauer
Publikováno v:
Annals of surgical oncology. 23(6)
Most patients with pancreatic ductal adenocarcinoma (PDAC) die within 5 years following resection plus adjuvant gemcitabine (Gem) from outgrowth of occult metastases. We hypothesized that inhibition of the KRAS pathway with the MEK inhibitor trametin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::800d1dcafd38f4d12526380c93893039
https://pubmed.ncbi.nlm.nih.gov/26847682
https://pubmed.ncbi.nlm.nih.gov/26847682
Autor:
Damien J. LaPar, James M. Lindberg, Todd W. Bauer, Timothy E. Newhook, Victor M. Zaydfudim, Reid B. Adams
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 19(6)
Patients with benign neoplasms of the pancreas are selected for pancreaticoduodenectomy if there is concern for malignant transformation. This study compares outcomes after pancreaticoduodenectomy for patients with premalignant and malignant pancreat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::020ceb9550e0799d4d5e1bdaa065f487
https://pubmed.ncbi.nlm.nih.gov/25801594
https://pubmed.ncbi.nlm.nih.gov/25801594
Autor:
Todd W. Bauer, J. Thomas Parsons, Jason A. Papin, James M. Lindberg, Sara J. Adair, Jae K. Lee, Wenjun Xin, Timothy E. Newhook, Edik M. Blais
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e105631 (2014)
PLoS ONE, Vol 9, Iss 9, p e105631 (2014)
Background Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinical staging system. Thus, more accurate prognostic tests are needed for PDAC patients to aid treatment decisions. Methods and Findings Affym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d409428002cfbbba356959b9422ef119
http://europepmc.org/articles/PMC4152146
http://europepmc.org/articles/PMC4152146